Topic: GlaxoSmithKline plc
Feds issue subpoena over Glaxo's diabetes pill Avandia, a month after FDA restricts its useBritish drug maker GlaxoSmithKline reported Thursday that its controversial diabetes drug Avandia is under investigation by federal and state law enforcement officials in the U.S.The announcement came less ...
The U.S. Food and Drug Administration has announced plans to substantially restrict the use of rosiglitazone (Avandia) in type 2 diabetes patients unable to control their disease with other medications.. The FDA is requiring the drug's manufacturer, GlaxoSmithKline, develop a restricted access ...
Just when you thought there was nothing new to say about Avandia, Time magazine reports - citing deputy FDA commissioner Josh Sharfstein - that the agency is investigating whether Glaxo broke the law by holding back from the FDA data indicating the ...
During hearings Tuesday into the safety of controversial diabetes drug Avandia, members of the U.S. government panel that could decide the drug's fate seemed skeptical of much of the data presented.. The hearing has coincided with news that the drug's maker, GlaxoSmithKline, ...
A majority of members of a key advisory committee recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale.Most of the panel's members agreed that the drug increases the risk of heart ...
Diabetes drug Avandia faces a moment of truth Wednesday, when a committee will decide whether to recommend pulling it from the market because it has been associated with increased heart problems.The committee, convened at the request of the Food and Drug Administration, ...
During hearings Tuesday into the safety of controversial diabetes drug Avandia, members of the U.S. government panel that could decide the drug's fate seemed skeptical of much of the data presented.. The hearing has coincided with news that the drug's maker, GlaxoSmithKline, ...
British pharmaceutical giant GlaxoSmithKline hid the dangers of its top-selling diabetes drug Avandia and secretly wrote scientific articles about it, two US lawmakers charged Tuesday.The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting of experts who will ...
UK pharmaceutical giant GlaxoSmithKline kept the dangers of its top-selling diabetes drug Avandia out of the public eye and ghostwrote scientific articles about it, US lawmakers charged Tuesday.The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting of ...
British pharmaceutical giant GlaxoSmithKline withheld from US drug safety regulators information about the possible dangers of top-selling diabetes drug Avandia, a report in the US press said Tuesday.The allegation was made in the Wall Street Journal on the day that Food and ...
Photo Gallery
From Around the Web
Video Gallery
-
News Update: New Study Shows GlaxoSmithKline ...
A study in the Journal of the American Medical Association ...2010-06-28 -
GlaxoSmithKline Plc (GSK)
Everyone is looking for a nice save haven in these ...2008-02-13 -
GlaxoSmithKline up 1%; Pronova Biopharma Settles ...
GlaxoSmithKline plc (GSK) shares are up 0.89% to $38 ...2011-03-30
